Mar 28, 2024 04:32PM
Jul 19, 2023 07:30AM
Mar 1, 2023 07:43AM
Feb 28, 2023 08:00AM
Feb 27, 2023 04:30PM
Feb 27, 2023 04:30PM
Feb 24, 2023 07:30AM KemPharm (KMPH) Announces Arimoclomol Research Featured in Two Poster Presentations
Feb 24, 2023 07:30AM
Feb 23, 2023 07:30AM
Feb 22, 2023 08:50AM
Feb 22, 2023 07:30AM
Jan 31, 2023 07:30AM
Jan 24, 2023 07:32AM
Jan 24, 2023 07:30AM KemPharm Issues Letter to Shareholders
Jan 18, 2023 07:30AM
Jan 11, 2023 07:31AM
Jan 11, 2023 07:30AM
Jan 9, 2023 06:38AM
Jan 9, 2023 06:30AM
Dec 21, 2022 07:30AM
Nov 29, 2022 07:33AM KemPharm (KMPH) Announces Appointment of Christopher Posner as New Independent Director
Nov 29, 2022 07:30AM
Nov 18, 2022 07:30AM
Nov 18, 2022 07:30AM
Nov 17, 2022 12:49PM
Nov 9, 2022 04:05PM
Nov 1, 2022 07:30AM
Oct 4, 2022 07:30AM KemPharm Supports Niemann-Pick Awareness Month During October and Global Niemann-Pick Awareness Day on October 19th
Sep 28, 2022 07:30AM
Sep 28, 2022 07:30AM
Sep 1, 2022 07:30AM
Aug 11, 2022 04:05PM
Aug 9, 2022 07:30AM
Aug 4, 2022 07:30AM
Aug 2, 2022 07:30AM KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference
Jul 26, 2022 08:30AM
Jun 1, 2022 08:32AM
Jun 1, 2022 08:30AM
May 16, 2022 05:20AM
May 15, 2022 08:00PM
May 11, 2022 07:30AM
May 5, 2022 07:31AM KemPharm (KMPH) Submits IND of Phase 2 Trial of KP1077 in Idiopathic Hypersomnia
May 5, 2022 07:30AM
May 4, 2022 04:30PM
Apr 19, 2022 07:30AM
Mar 30, 2022 04:05PM
Mar 24, 2022 08:00AM
Mar 21, 2022 07:30AM
Mar 21, 2022 07:30AM KemPharm Announces Full Data Set from Higher-Dose Serdexmethylphenidate (SDX) Phase 1 Clinical Trial
Mar 16, 2022 07:35AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All